Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tesařová

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 11, 2013
[OPERa Study]P Tesařová
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 26, 2017
[Pregnancy-associated Breast Cancer]P Tesařová
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|June 29, 2021
Breast cancer medical oncology summary 2021P Tesařová
Folia Biologica|March 30, 2013
Proteinuria and hypertension in patients treated with inhibitors of the VEGF signalling pathway--incidence, mechanisms and managementP Tesařová, V Tesař
Folia Biologica|August 2, 2012
Disseminated and circulating tumour cells and their role in breast cancerM Čabiňaková, P Tesařová
Physiological Research|December 19, 2015
Contribution of ABCB1 and CYP2D6 genotypes to the outcome of tamoxifen adjuvant treatment in premenopausal women with breast cancerS Argalácsová, O Slanař, P Vítek, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 11, 2013
[OPERa Study]P Tesařová
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 26, 2017
[Pregnancy-associated Breast Cancer]P Tesařová
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|June 29, 2021
Breast cancer medical oncology summary 2021P Tesařová
Folia Biologica|March 30, 2013
Proteinuria and hypertension in patients treated with inhibitors of the VEGF signalling pathway--incidence, mechanisms and managementP Tesařová, V Tesař
Folia Biologica|August 2, 2012
Disseminated and circulating tumour cells and their role in breast cancerM Čabiňaková, P Tesařová
Physiological Research|December 19, 2015
Contribution of ABCB1 and CYP2D6 genotypes to the outcome of tamoxifen adjuvant treatment in premenopausal women with breast cancerS Argalácsová, O Slanař, P Vítek, et al.
Pageof 1